Brief: Health Canada Grants License For Quidel® Triagetrue® High-Sensitivity Troponin I Test To Aid In The Diagnosis Of Myocardial Infarction
19/12/2022 20:16
Quidelortho Corp QDEL.O :
* HEALTH CANADA GRANTS LICENSE FOR QUIDEL® TRIAGETRUE®
HIGH-SENSITIVITY TROPONIN I TEST TO AID IN THE DIAGNOSIS OF
MYOCARDIAL INFARCTION
Source text for Eikon: ID:nBw7zvMXZa
Further company coverage: QDEL.O
Recent news on Quidelortho
See all newsBrief: Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026
QuidelOrtho Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: QuidelOrtho Q2 EPS USD -1.36
Media: QuidelOrtho looks to sell testing unit as PE circles healthcare companies - FT
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras